351323 <common-name>(5z)-3-(1,3-benzodioxol-5-ylmethyl)-5-[[3-(4-butoxyphenyl)-1-phenylpyrazol-4-yl]methylidene]-2-sulfanylidene-1,3-thiazolidin-4-one</common-name> <description>(5z)-3-(1,3-benzodioxol-5-ylmethyl)-5-[[3-(4-butoxyphenyl)-1-phenylpyrazol-4-yl]methylidene]-2-sulfanylidene-1,3-thiazolidin-4-one is a chemical compound with the formula C31H27N3O4S2. With an average molecular weight of 569.70 g/mol, (5z)-3-(1,3-benzodioxol-5-ylmethyl)-5-[[3-(4-butoxyphenyl)-1-phenylpyrazol-4-yl]methylidene]-2-sulfanylidene-1,3-thiazolidin-4-one is a heavy molecule.</description> <cas>623935-29-5</cas> <pubchem-id>6268645</pubchem-id> <chemical-formula>C31H27N3O4S2</chemical-formula> <weight>569.7</weight> <appearance nil="true"/> <melting-point nil="true"/> <boiling-point nil="true"/> <density nil="true"/> <solubility nil="true"/> <specific-gravity nil="true"/> <flash-point nil="true"/> <vapour-pressure nil="true"/> <route-of-exposure nil="true"/> <target nil="true"/> <mechanism-of-toxicity nil="true"/> <metabolism nil="true"/> <toxicity nil="true"/> <lethaldose nil="true"/> <carcinogenicity nil="true"/> <use-source nil="true"/> <min-risk-level nil="true"/> <health-effects nil="true"/> <symptoms nil="true"/> <treatment nil="true"/> <created-at type="dateTime">2026-08-31T16:57:53Z</created-at> <updated-at type="dateTime">2026-08-31T16:57:53Z</updated-at> <interacting-proteins nil="true"/> <wikipedia nil="true"/> <uniprot-id nil="true"/> <kegg-compound-id nil="true"/> <omim-id nil="true"/> <chebi-id nil="true"/> <biocyc-id nil="true"/> <ctd-id nil="true"/> <stitch-id nil="true"/> <drugbank-id nil="true"/> <pdb-id nil="true"/> <actor-id nil="true"/> <organism nil="true"/> <export type="boolean">true</export> <metabolizing-proteins nil="true"/> <transporting-proteins nil="true"/> <moldb-smiles>CCCCOC1=CC=C(C=C1)C2=NN(C=C2C=C3C(=O)N(C(=S)S3)CC4=CC5=C(C=C4)OCO5)C6=CC=CC=C6</moldb-smiles> <moldb-formula>C31H27N3O4S2</moldb-formula> <moldb-inchi>InChI=1S/C31H27N3O4S2/c1-2-3-15-36-25-12-10-22(11-13-25)29-23(19-34(32-29)24-7-5-4-6-8-24)17-28-30(35)33(31(39)40-28)18-21-9-14-26-27(16-21)38-20-37-26/h4-14,16-17,19H,2-3,15,18,20H2,1H3/b28-17-</moldb-inchi> <moldb-inchikey>URKOPHAVGVPHRW-QRQIAZFYSA-N</moldb-inchikey> <moldb-average-mass type="decimal" nil="true"/> <moldb-mono-mass type="decimal">569.1442987</moldb-mono-mass> <origin nil="true"/> <state nil="true"/> <logp>7.1</logp> <hmdb-id nil="true"/> <chembl-id nil="true"/> <chemspider-id nil="true"/> <structure-image-file-name nil="true"/> <structure-image-content-type nil="true"/> <structure-image-file-size type="integer" nil="true"/> <structure-image-updated-at type="dateTime" nil="true"/> <biodb-id nil="true"/> <synthesis-reference nil="true"/> <structure-image-caption nil="true"/> <chemdb-id>CHEM347216</chemdb-id> <dsstox-id nil="true"/> <toxcast-id nil="true"/> <stoff-ident-origin nil="true"/> <stoff-ident-id nil="true"/> <susdat-id nil="true"/> <iupac>(5z)-3-(1,3-benzodioxol-5-ylmethyl)-5-[[3-(4-butoxyphenyl)-1-phenylpyrazol-4-yl]methylidene]-2-sulfanylidene-1,3-thiazolidin-4-one</iupac> <moldb-polar-surface-area nil="true"/> <moldb-refractivity nil="true"/> <moldb-polarizability nil="true"/> <moldb-rotatable-bond-count nil="true"/> <moldb-acceptor-count nil="true"/> <moldb-donor-count nil="true"/> <moldb-pka-strongest-acidic nil="true"/> <moldb-pka-strongest-basic nil="true"/> <moldb-physiological-charge nil="true"/> <moldb-number-of-rings nil="true"/> <moldb-alogps-logp nil="true"/> <moldb-alogps-logs nil="true"/> <moldb-alogps-solubility nil="true"/> <kingdom>Organic compounds</kingdom> <superklass>Organoheterocyclic compounds</superklass> <klass>Azoles</klass> <subklass>Pyrazoles</subklass> <paper-count type="integer" nil="true"/> <sync-id>CED0301623</sync-id> <structure-inchikey>URKOPHAVGVPHRW-UHFFFAOYSA-N</structure-inchikey> <structure-fingerprint>40000000000000000800042000000000000000000000000000100000000000000404002000220300000000000002004000000000000400000811000000000000000000000000000090000000000000020800010000300000200002080000000000020000000000000000100110000800008020100108040000000000000000030004140000000800000000000000000800000000100000000000000000000000000000000000004000000080000000000000020090000020200040020000000000000000000000001000000010000000000000000040000000220040000000080000040000000010040000000c10000000000080000000000000200000008</structure-fingerprint> <structure-pattern-fingerprint>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</structure-pattern-fingerprint> <structure-pickle type="binary" encoding="base64">776t3gAAAAAQAAAAAwAAAAAAAAAoAAAALQAAAIABBgBgAAAAAQMGAGAAAAAC AgYAYAAAAAICBgBgAAAAAgIIACgAAAADAgZAKAAAAAMEBkBoAAAAAwMBBkBo AAAAAwMBBkAoAAAAAwQGQGgAAAADAwEGQGgAAAADAwEGQCgAAAADBAdAKAAA AAMDB0AoAAAAAwMGQGgAAAADAwEGQCgAAAADBAYAaAAAAAMDAQYAKAAAAAME BgAoAAAAAwQIACgAAAADAgcAKAAAAAMDBgAoAAAAAwQQACgAAAADAhAAIAAA AAIGAGAAAAACAgZAKAAAAAMEBkBoAAAAAwMBBkAoAAAAAwQGQCgAAAADBAZA aAAAAAMDAQZAaAAAAAMDAQgAKAAAAAMCBgBgAAAAAgIIACgAAAADAgZAKAAA AAMEBkBoAAAAAwMBBkBoAAAAAwMBBkBoAAAAAwMBBkBoAAAAAwMBBkBoAAAA AwMBCwABAAECAAIDAAMEAAQFIAUGaAwGB2gMBwhoDAgJaAwJCmgMCAsgCwxo DAwNaAwNDmgMDg9oDA8QIBARKAIREiASEygCEhQgFBUgFRYoAhUXABQYABgZ ABkaaAwaG2gMGxxoDBwdaAwdHmgMHB8gHyAAICEADSIgIiNoDCMkaAwkJWgM JSZoDCYnaAwKBWgMDwtoDBcRAB4ZaAwhGyAnImgMQgYAAAAGBQoJCAcGBQwL Dw4NBRIRFxUUBhobHB0eGQUfHBshIAYjJCUmJyIXBAAAAAAAAAAW </structure-pickle> <structure-indexed-at type="dateTime">2026-09-19T05:49:15Z</structure-indexed-at> </compound>